
Aegon has completed a £2 billion transaction with Standard Life that unlocks significant value and supports its strategy of deleveraging and share buybacks. This deal simplifies Aegon's corporate structure, making it easier for investors to understand and value the company as it shifts focus towards a more U.S.-centric business model. Aegon's stakes in a.s.r. and Standard Life represent over 40% of its market capitalization, while its core operations continue to generate around €1.2 billion in operating capital. The company's valuation remains attractive, encouraging continued investor interest.